BETH METTES: Open Payments
NPI 1487132056 · MACON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 28 payments from 17 companies in 2025. Trend: 2023 $199 · 2024 $294 · 2025 $665
Food & beverage: $565Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $144 |
| ABBVIE INC. | 2 | $119 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| ARRAY BIOPHARMA INC | 3 | $52 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| PFIZER INC. | 2 | $32 |
| Incyte Corporation | 1 | $27 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| Celltrion USA Inc. | 1 | $20 |
Products named: RYBREVANT, VRAYLAR, KEYTRUDA, XALKORI, JAKAFI, MONOFERRIC, PLUVICTO, VEGZELMA.
Industry payments across MO — which companies pay providers there.
